Which major pharmaceutical company underwent a complete brand identity transformation in 2020, changing its logo, colors, and messaging to reflect a shift toward patient-centered digital health solutions?

In the competitive pharmaceutical industry, brand identity plays a crucial role in establishing trust with healthcare professionals and patients. Companies invest millions in creating distinctive identities that communicate reliability, innovation, and patient care values. This trivia tests your knowledge about a significant pharmaceutical brand evolution that marked a strategic shift in the company's market positioning and communication approach.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Novartis, with its 'Reimagining Medicine' campaign featuring a new stylized 'N' symbol and transition from blue to multicolor gradient visual identity
Pfizer, with its 'Science Will Win' campaign featuring a new double helix logo and transition from blue to green color scheme
Merck, with its 'Inventing for Life' campaign featuring a new molecular structure logo and transition from green to purple visual identity
AstraZeneca, with its 'Health Forward' campaign featuring a new pulse symbol logo and transition from red to blue gradient visual identity